{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:18:23Z","timestamp":1783635503708,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jacc.2022.08.747","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T08:14:07Z","timestamp":1661760847000},"page":"1802-1814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"80","author":[{"given":"Barbara E.","family":"St\u00e4hli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Klingenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik","family":"Heg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Manka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kapos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"M\u00fcggler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Denegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Kesterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stehli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Candreva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Moccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pedrazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Templin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers."},{"issue":"7","key":"10.1016\/j.jacc.2022.08.747_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","article-title":"Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities","volume":"115","author":"Andreadou","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.jacc.2022.08.747_bib4","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jacc.2022.08.747_bib5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2009.12.037","article-title":"Microvascular obstruction: underlying pathophysiology and clinical diagnosis","volume":"55","author":"Bekkers","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2022.08.747_bib6","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.jacc.2022.08.747_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.jacc.2022.08.747_bib9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.jacc.2022.08.747_bib10","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacc.2022.08.747_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2006.04.014","article-title":"Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes","volume":"41","author":"Khan","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"12","key":"10.1016\/j.jacc.2022.08.747_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/hh2401.101385","article-title":"Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling","volume":"89","author":"Jonassen","year":"2001","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/cmi.2014.24","article-title":"Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation","volume":"12","author":"Vitiello","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jacc.2022.08.747_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vph.2018.12.004","article-title":"Everolimus depletes plaque macrophages, abolishes intraplaque neovascularization and improves survival in mice with advanced atherosclerosis","volume":"113","author":"Kurdi","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"5","key":"10.1016\/j.jacc.2022.08.747_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"25","key":"10.1016\/j.jacc.2022.08.747_bib17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","article-title":"Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction","volume":"54","author":"Buss","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.08.747_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2022.01.010","article-title":"Controlled-Level Everolimus in Acute Coronary Syndrome (CLEVER-ACS) \u2014 a phase II, randomized, double-blind, multi-center, placebo-controlled trial","volume":"247","author":"Klingenberg","year":"2022","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2022.08.747_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1148\/radiol.11102216","article-title":"Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging","volume":"259","author":"Goetti","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1148\/radiol.11110228","article-title":"Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling","volume":"261","author":"Mather","year":"2011","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2009.04.021","article-title":"Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction","volume":"54","author":"Tsujioka","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacc.2018.04.053","article-title":"Association of IL-8 with infarct size and clinical outcomes in patients with STEMI","volume":"72","author":"Shetelig","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.jacc.2022.08.747_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jacc.2022.08.747_bib26","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.08.747_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2017.02.028","article-title":"Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: a patient-level analysis of randomized clinical trials","volume":"188","author":"Selker","year":"2017","journal-title":"Am Heart J"},{"issue":"13","key":"10.1016\/j.jacc.2022.08.747_bib28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2013.01.048","article-title":"Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial","volume":"61","author":"Eitel","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jacc.2022.08.747_bib29","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2016.08.047","article-title":"Computed tomography and cardiac magnetic resonance in ischemic heart disease","volume":"68","author":"Dweck","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jcmg.2020.12.022","article-title":"USPIO-enhanced CMR of myocardial inflammation: what are we imaging?","volume":"14","author":"Fayad","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"5","key":"10.1016\/j.jacc.2022.08.747_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcmg.2016.02.029","article-title":"Clinical utility of combined FDG-PET\/MR to assess myocardial disease","volume":"10","author":"Abgral","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"issue":"7","key":"10.1016\/j.jacc.2022.08.747_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.0000138935.17503.35","article-title":"Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial","volume":"110","author":"Hausleiter","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCIMAGING.108.802199","article-title":"Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI","volume":"2","author":"Engblom","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.jacc.2022.08.747_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcin.2019.01.248","article-title":"Complete revascularization versus culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease: a DANAMI-3-PRIMULTI cardiac magnetic resonance substudy","volume":"12","author":"Kyhl","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"7","key":"10.1016\/j.jacc.2022.08.747_bib35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","article-title":"Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment","volume":"3","author":"McCarthy","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2022.08.747_bib36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jacc.2005.12.052","article-title":"Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) study","volume":"47","author":"Rodriguez","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2022.08.747_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/eurheartj\/ehp259","article-title":"Rapamycin promotes arterial thrombosis in\u00a0vivo: implications for everolimus and zotarolimus eluting stents","volume":"31","author":"Camici","year":"2010","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jacc.2022.08.747_bib38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jacc.2022.08.747_bib39","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/archinte.164.22.2472","article-title":"Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction","volume":"164","author":"Fischer","year":"2004","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jacc.2022.08.747_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2009.04.008","article-title":"Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal","volume":"207","author":"Sposito","year":"2009","journal-title":"Atherosclerosis"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972206613X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972206613X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:51:34Z","timestamp":1760017894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972206613X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S073510972206613X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.08.747","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.08.747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}